Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06IBV
|
|||
Former ID |
DNC002708
|
|||
Drug Name |
Heptyl-Beta-D-Glucopyranoside
|
|||
Synonyms |
78617-12-6; HEPTYL-BETA-D-GLUCOPYRANOSIDE; Heptyl beta-D-glucopyranoside; (2R,3R,4S,5S,6R)-2-(Heptyloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; Heptyl-b-D-glucopyranoside; Heptyl b-D-glucopyranoside; B7G; n-Heptyl-I(2)-D-glucopyranoside; AC1L9LOI; heptyl-; n-Heptyl-ss-D-glucopyranosid; SCHEMBL333088; MolPort-003-935-703; C13H26O6; ZINC48016017; MFCD00063299; GC5331; AKOS027251086; DB03338; API0002901; AK187162; W0562; FT-0626931; n-Heptyl beta-D-glucopyranoside, ~98% (GC); A-7798; n-Heptyl beta-D-gluc
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C13H26O6
|
|||
Canonical SMILES |
CCCCCCCOC1C(C(C(C(O1)CO)O)O)O
|
|||
InChI |
1S/C13H26O6/c1-2-3-4-5-6-7-18-13-12(17)11(16)10(15)9(8-14)19-13/h9-17H,2-8H2,1H3/t9-,10-,11+,12-,13-/m1/s1
|
|||
InChIKey |
NIDYWHLDTIVRJT-UJPOAAIJSA-N
|
|||
CAS Number |
CAS 78617-12-6
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | FK506-binding protein 1A (FKBP1A) | Target Info | Inhibitor | [1] |
Peroxisome proliferator-activated receptor delta (PPARD) | Target Info | Inhibitor | [1] | |
KEGG Pathway | PPAR signaling pathway | |||
Wnt signaling pathway | ||||
Pathways in cancer | ||||
Acute myeloid leukemia | ||||
NetPath Pathway | IL2 Signaling Pathway | |||
Panther Pathway | Wnt signaling pathway | |||
Pathway Interaction Database | Presenilin action in Notch and Wnt signaling | |||
RXR and RAR heterodimerization with other nuclear receptor | ||||
Reactome | Import of palmitoyl-CoA into the mitochondrial matrix | |||
Regulation of pyruvate dehydrogenase (PDH) complex | ||||
Nuclear Receptor transcription pathway | ||||
WikiPathways | Wnt Signaling Pathway and Pluripotency | |||
Nuclear Receptors in Lipid Metabolism and Toxicity | ||||
NRF2 pathway | ||||
Nuclear Receptors Meta-Pathway | ||||
Vitamin D Receptor Pathway | ||||
Ectoderm Differentiation | ||||
Adipogenesis | ||||
Nuclear Receptors |
References | Top | |||
---|---|---|---|---|
REF 1 | DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.